RNA-seq to investigate impact of treatment of KRAS mutant NCI-H358 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib
RNA-Seq mRNA differential
Organism:
Homo sapiens
Publication
- Kruspig B, Monteverde T, Neidler S, Hock A, Kerr E et al. (2018) The ERBB network facilitates KRAS-driven lung tumorigenesis.